Study predicts most people with earliest Alzheimer's signs won't develop dementia associated with the disease

May 22, 2018 by Stephanie Cajigal, University of California, Los Angeles
According to a new UCLA study, most people with preclinical signs of Alzheimer’s will not develop the full-scale disease. Credit: obencem/123rf.com

During the past decade, researchers have identified new ways to detect the earliest biological signs of Alzheimer's disease. These early signs, which are detected by biomarkers, may be present before a person starts to exhibit physical symptoms. What biomarker screening doesn't reveal, however, is how likely it is that a person who tests positive will eventually develop the dementia associated with Alzheimer's disease.

That's where the new predictions from researchers at the UCLA Fielding School of Public Health may be helpful. In a paper published by Alzheimer's & Dementia: The Journal of the Alzheimer's Association, the authors lay out the probabilities that a person will develop Alzheimer's based on age, gender and the results of tests, which can detect the presence of certain protein fragments in brain and spinal fluid or brain cell changes linked with the disease. The estimates show that most people with preclinical signs of Alzheimer's disease dementia will not develop the full-scale disease.

"Lifetime risk estimates can help doctors and other health care providers evaluate whether or not a positive screening test means a patient is likely to develop Alzheimer's disease dementia," said Ron Brookmeyer, the study's lead author and a professor of biostatistics at the Fielding School. "These estimates may reassure some people that despite testing positive on screening tests, their chances of developing Alzheimer's disease dementia are low."

Brookmeyer and Nada Abdalla, a doctoral candidate at the Fielding School, drew data from previous studies that tracked the progression of Alzheimer's disease in thousands of people and included that information in a computer model that also incorporated published U.S. death rates. They found, for example, that a 60-year-old woman without any biomarkers for Alzheimer's has about a 20 percent chance of developing Alzheimer's disease dementia. A woman of the same age would have a 96 percent chance if she already has shown some decline in memory and thinking skills and if biomarker screening has detected amyloid protein and neurodegeneration in her brain.

Men have a lower risk of developing Alzheimer's disease dementia because their average lifespan is shorter. A 60-year-old man with no biological signs of Alzheimer's, for example, has about a 14 percent risk for developing Alzheimer's disease dementia, according to the paper.

Brookmeyer said interventions to slow the progression of the disease could significantly lower a person's risk of developing Alzheimer's disease dementia.

Explore further: Model estimates lifetime risk of Alzheimer's dementia using biomarkers

Related Stories

Model estimates lifetime risk of Alzheimer's dementia using biomarkers

May 22, 2018
Lifetime risks of developing Alzheimer's disease dementia vary considerably by age, gender and whether any signs or symptoms of dementia are present, according to a new study published online by Alzheimer's & Dementia.

Population of Americans with Alzheimer's will more than double by 2060, study shows

December 7, 2017
About 15 million Americans will have either Alzheimer's dementia or mild cognitive impairment by 2060, up from approximately 6.08 million this year, according to a new study by researchers at the UCLA Fielding School of Public ...

New forecast shows 6 million with Alzheimer's disease, cognitive impairment

December 8, 2017
Using new methodology, scientists calculate that approximately 6 million American adults have Alzheimer's disease or mild cognitive impairment, which can sometimes be a precursor to the disease. The estimate, funded by the ...

New way of defining Alzheimer's aims to find disease sooner

April 10, 2018
Government and other scientists are proposing a new way to define Alzheimer's disease—basing it on biological signs, such as brain changes, rather than memory loss and other symptoms of dementia that are used today.

Sleep problem linked to changes in hallmark Alzheimer's protein

November 10, 2017
Researchers in the US have found a link between the sleep disorder, obstructive sleep apnoea, and levels of a protein involved in Alzheimer's disease. Their findings are published today in the American Journal of Respiratory ...

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

December 7, 2016
The hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Eastern Finland. However, the incidence of hip fracture is higher among ...

Recommended for you

Scientists discover why some people with brain markers of Alzheimer's have no dementia

August 16, 2018
A new study from The University of Texas Medical Branch at Galveston has uncovered why some people that have brain markers of Alzheimer's never develop the classic dementia that others do. The study is now available in the ...

Researchers identify new genes that may contribute to Alzheimer's disease

August 14, 2018
Researchers from Boston University School of Medicine, working with scientists across the nation on the Alzheimer's Disease Sequencing Project (ADSP), have discovered new genes that will further current understanding of the ...

Deaths from resident-to-resident incidents in dementia offers insights to inform policy

August 14, 2018
Analyzing the incidents between residents in dementia in long-term care homes may hold the key to reducing future fatalities among this vulnerable population, according to new research from the University of Minnesota School ...

Scientists propose a new lead for Alzheimer's research

August 14, 2018
A University of Adelaide-led team of scientists has suggested a potential link between iron in our cells and the rare gene mutations that cause Alzheimer's disease, which could provide new avenues for future research.

Eye conditions provide new lens screening for Alzheimer's disease

August 8, 2018
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.

Potential indicator for the early detection of dementias

August 7, 2018
Researchers at the University of Basel have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.